<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>30(5)</volume><submitter>Kandeel MM</submitter><funding>STDF-RSG, Egypt</funding><pubmed_abstract>A series of indolinone-based derivatives were designed and synthesized using the hybrid pharmacophoric design approach as cytotoxic kinase inhibitors. The cytotoxic effects of the designed molecules were tested against MCF-7 and HepG-2 cell lines. Compounds &lt;b>9&lt;/b> and &lt;b>20&lt;/b> were the most cytotoxic, with IC&lt;sub>50&lt;/sub> values against HepG-2 and MCF-7 cells ranging from 2.53 to 7.54 µM. Additionally, compounds &lt;b>9&lt;/b> and &lt;b>20&lt;/b> were also found to be slightly more cytotoxic than indirubin with 2.2-2.7-fold higher cytotoxicity with HepG-2 cells. CDK-2 and CDK-4 kinase enzyme inhibition assay showed that compound &lt;b>9&lt;/b> had a higher inhibitory effect (4.8-fold) than indirubin against CDK-2 and comparable inhibition against CDK-4. Moreover, compound &lt;b>20&lt;/b> displayed nanomolar in</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pagination>1105</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11901902</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Design, Synthesis, and Cytotoxicity Evaluation of Novel Indolin-2-One Based Molecules on Hepatocellular Carcinoma HepG2 Cells as Protein Kinase Inhibitors.</pubmed_title><pmcid>PMC11901902</pmcid><pubmed_authors>AbdElhameid MK</pubmed_authors><pubmed_authors>Al-Shorbagy MY</pubmed_authors><pubmed_authors>Kandeel MM</pubmed_authors><pubmed_authors>Adel M</pubmed_authors><pubmed_authors>Negmeldin AT</pubmed_authors></additional><is_claimable>false</is_claimable><name>Design, Synthesis, and Cytotoxicity Evaluation of Novel Indolin-2-One Based Molecules on Hepatocellular Carcinoma HepG2 Cells as Protein Kinase Inhibitors.</name><description>A series of indolinone-based derivatives were designed and synthesized using the hybrid pharmacophoric design approach as cytotoxic kinase inhibitors. The cytotoxic effects of the designed molecules were tested against MCF-7 and HepG-2 cell lines. Compounds &lt;b>9&lt;/b> and &lt;b>20&lt;/b> were the most cytotoxic, with IC&lt;sub>50&lt;/sub> values against HepG-2 and MCF-7 cells ranging from 2.53 to 7.54 µM. Additionally, compounds &lt;b>9&lt;/b> and &lt;b>20&lt;/b> were also found to be slightly more cytotoxic than indirubin with 2.2-2.7-fold higher cytotoxicity with HepG-2 cells. CDK-2 and CDK-4 kinase enzyme inhibition assay showed that compound &lt;b>9&lt;/b> had a higher inhibitory effect (4.8-fold) than indirubin against CDK-2 and comparable inhibition against CDK-4. Moreover, compound &lt;b>20&lt;/b> displayed nanomolar in</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Feb</publication><modification>2026-04-08T19:48:44.913Z</modification><creation>2025-04-04T09:08:14.277Z</creation></dates><accession>S-EPMC11901902</accession><cross_references><pubmed>40076329</pubmed><doi>10.3390/molecules30051105</doi></cross_references></HashMap>